Flinton Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-131
| Closed | -$66K | – | 892 |
|
|
2019
Q2 | $66K | Sell |
131
-41
| -24% | -$20.7K | ﹤0.01% | 818 |
|
|
2019
Q1 | $170K | Sell |
172
-172
| -50% | -$170K | 0.01% | 700 |
|
|
2018
Q4 | $299K | Sell |
344
-164
| -32% | -$143K | 0.01% | 560 |
|
|
2018
Q3 | $525K | Buy |
508
+35
| +7% | +$36.2K | 0.02% | 485 |
|
|
2018
Q2 | $435K | Buy |
473
+12
| +3% | +$11K | 0.01% | 457 |
|
|
2018
Q1 | $449K | Buy |
461
+389
| +540% | +$379K | 0.02% | 441 |
|
|
2017
Q4 | $32K | Sell |
72
-48
| -40% | -$21.3K | ﹤0.01% | 830 |
|
|
2017
Q3 | $50K | Sell |
120
-15
| -11% | -$6.25K | ﹤0.01% | 801 |
|
|
2017
Q2 | $47K | Sell |
135
-44
| -25% | -$15.3K | ﹤0.01% | 799 |
|
|
2017
Q1 | $92K | Hold |
179
| – | – | ﹤0.01% | 651 |
|
|
2016
Q4 | $64K | Buy |
+179
| New | +$64K | ﹤0.01% | 679 |
|